212 related articles for article (PubMed ID: 28103256)
1. Tumor Infiltration in Enhancing and Non-Enhancing Parts of Glioblastoma: A Correlation with Histopathology.
Eidel O; Burth S; Neumann JO; Kieslich PJ; Sahm F; Jungk C; Kickingereder P; Bickelhaupt S; Mundiyanapurath S; Bäumer P; Wick W; Schlemmer HP; Kiening K; Unterberg A; Bendszus M; Radbruch A
PLoS One; 2017; 12(1):e0169292. PubMed ID: 28103256
[TBL] [Abstract][Full Text] [Related]
2. Nuclear Overhauser Enhancement imaging of glioblastoma at 7 Tesla: region specific correlation with apparent diffusion coefficient and histology.
Paech D; Burth S; Windschuh J; Meissner JE; Zaiss M; Eidel O; Kickingereder P; Nowosielski M; Wiestler B; Sahm F; Floca RO; Neumann JO; Wick W; Heiland S; Bendszus M; Schlemmer HP; Ladd ME; Bachert P; Radbruch A
PLoS One; 2015; 10(3):e0121220. PubMed ID: 25789657
[TBL] [Abstract][Full Text] [Related]
3. Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging.
Barajas RF; Phillips JJ; Parvataneni R; Molinaro A; Essock-Burns E; Bourne G; Parsa AT; Aghi MK; McDermott MW; Berger MS; Cha S; Chang SM; Nelson SJ
Neuro Oncol; 2012 Jul; 14(7):942-54. PubMed ID: 22711606
[TBL] [Abstract][Full Text] [Related]
4. Automatic Analysis of Cellularity in Glioblastoma and Correlation with ADC Using Trajectory Analysis and Automatic Nuclei Counting.
Eidel O; Neumann JO; Burth S; Kieslich PJ; Jungk C; Sahm F; Kickingereder P; Kiening K; Unterberg A; Wick W; Schlemmer HP; Bendszus M; Radbruch A
PLoS One; 2016; 11(7):e0160250. PubMed ID: 27467557
[TBL] [Abstract][Full Text] [Related]
5. Increased Delay Between Gadolinium Chelate Administration and T1-Weighted Magnetic Resonance Imaging Acquisition Increases Contrast-Enhancing Tumor Volumes and T1 Intensities in Brain Tumor Patients.
Piechotta PL; Bonekamp D; Sill M; Wick A; Wick W; Bendszus M; Kickingereder P
Invest Radiol; 2018 Apr; 53(4):223-228. PubMed ID: 29200014
[TBL] [Abstract][Full Text] [Related]
6. Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy.
Earnest F; Kelly PJ; Scheithauer BW; Kall BA; Cascino TL; Ehman RL; Forbes GS; Axley PL
Radiology; 1988 Mar; 166(3):823-7. PubMed ID: 2829270
[TBL] [Abstract][Full Text] [Related]
7. Pathologic analysis of glioblastoma via multiple stereotactic biopsies of active tumor and necrosis.
Jung TY; Jung S; Kim IY; Moon KS; Jang WY; Park SJ; Kim YH; Kim HS; Min JJ; Kim J
Oncol Rep; 2012 Mar; 27(3):707-13. PubMed ID: 22024963
[TBL] [Abstract][Full Text] [Related]
8. A Multiparametric Model for Mapping Cellularity in Glioblastoma Using Radiographically Localized Biopsies.
Chang PD; Malone HR; Bowden SG; Chow DS; Gill BJA; Ung TH; Samanamud J; Englander ZK; Sonabend AM; Sheth SA; McKhann GM; Sisti MB; Schwartz LH; Lignelli A; Grinband J; Bruce JN; Canoll P
AJNR Am J Neuroradiol; 2017 May; 38(5):890-898. PubMed ID: 28255030
[TBL] [Abstract][Full Text] [Related]
9. The clinical utility of multimodal MR image-guided needle biopsy in cerebral gliomas.
Yao C; Lv S; Chen H; Tang W; Guo J; Zhuang D; Chrisochoides N; Wu J; Mao Y; Zhou L
Int J Neurosci; 2016; 126(1):53-61. PubMed ID: 25539452
[TBL] [Abstract][Full Text] [Related]
10. Super-resolution track density imaging of glioblastoma: histopathologic correlation.
Barajas RF; Hess CP; Phillips JJ; Von Morze CJ; Yu JP; Chang SM; Nelson SJ; McDermott MW; Berger MS; Cha S
AJNR Am J Neuroradiol; 2013 Jul; 34(7):1319-25. PubMed ID: 23413250
[TBL] [Abstract][Full Text] [Related]
11. Differentiation between vasogenic-edema versus tumor-infiltrative area in patients with glioblastoma during bevacizumab therapy: a longitudinal MRI study.
Artzi M; Bokstein F; Blumenthal DT; Aizenstein O; Liberman G; Corn BW; Ben Bashat D
Eur J Radiol; 2014 Jul; 83(7):1250-1256. PubMed ID: 24809637
[TBL] [Abstract][Full Text] [Related]
12. Tumor detection with 5-aminolevulinic acid fluorescence and Gd-DTPA-enhanced intraoperative MRI at the border of contrast-enhancing lesions: a prospective study based on histopathological assessment.
Coburger J; Engelke J; Scheuerle A; Thal DR; Hlavac M; Wirtz CR; König R
Neurosurg Focus; 2014 Feb; 36(2):E3. PubMed ID: 24484256
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis of brain gliomas in stereotactic biopsy assisted by optical neuro-navigation system].
Nowacki P; Tabaka J; Jezewski D; Honczarenko K
Neurol Neurochir Pol; 2004; 38(1):3-8. PubMed ID: 15049161
[TBL] [Abstract][Full Text] [Related]
14. Which combination of MR imaging modalities is best for predicting recurrent glioblastoma? Study of diagnostic accuracy and reproducibility.
Kim HS; Goh MJ; Kim N; Choi CG; Kim SJ; Kim JH
Radiology; 2014 Dec; 273(3):831-43. PubMed ID: 24885857
[TBL] [Abstract][Full Text] [Related]
15. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
[TBL] [Abstract][Full Text] [Related]
16. Quantitative T1 mapping indicates tumor infiltration beyond the enhancing part of glioblastomas.
Nöth U; Tichy J; Tritt S; Bähr O; Deichmann R; Hattingen E
NMR Biomed; 2020 Mar; 33(3):e4242. PubMed ID: 31880005
[TBL] [Abstract][Full Text] [Related]
17. Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms.
Kelly PJ; Daumas-Duport C; Kispert DB; Kall BA; Scheithauer BW; Illig JJ
J Neurosurg; 1987 Jun; 66(6):865-74. PubMed ID: 3033172
[TBL] [Abstract][Full Text] [Related]
18. Tryptophan PET predicts spatial and temporal patterns of post-treatment glioblastoma progression detected by contrast-enhanced MRI.
Bosnyák E; Kamson DO; Robinette NL; Barger GR; Mittal S; Juhász C
J Neurooncol; 2016 Jan; 126(2):317-25. PubMed ID: 26514361
[TBL] [Abstract][Full Text] [Related]
19. Using intraoperative dynamic contrast-enhanced T1-weighted MRI to identify residual tumor in glioblastoma surgery.
Özduman K; Yıldız E; Dinçer A; Sav A; Pamir MN
J Neurosurg; 2014 Jan; 120(1):60-6. PubMed ID: 24138206
[TBL] [Abstract][Full Text] [Related]
20. Surgical management and outcome of newly diagnosed glioblastoma without contrast enhancement (low-grade appearance): a report of the RANO resect group.
Karschnia P; Dietrich J; Bruno F; Dono A; Juenger ST; Teske N; Young JS; Sciortino T; Häni L; van den Bent M; Weller M; Vogelbaum MA; Morshed RA; Haddad AF; Molinaro AM; Tandon N; Beck J; Schnell O; Bello L; Hervey-Jumper S; Thon N; Grau SJ; Esquenazi Y; Rudà R; Chang SM; Berger MS; Cahill DP; Tonn JC
Neuro Oncol; 2024 Jan; 26(1):166-177. PubMed ID: 37665776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
